Bill Ratner, AbbVie

Bill Ratner, AbbVie

Vice President, US Dermatology

Bill is the Vice President for US Psoriatic and HS Dermatology sales and marketing. In this role, he leads the commercial promotion of Skyrizi for Psoriatic Disease and HUMIRA for Hidradenitis Suppurativa (HS) and Psoriatic Disease.

Bill led the strategy for the development of the Skyrizi brand and its initial launch in psoriasis where it is now recognized as one the most successful launch ever of a product in Dermatology, measured by rate of adoption and speed to reach and exceed $1 billion in sales.

Prior to AbbVie, Bill spent nineteen years in the commercial organization of Eli Lilly and Company. During his tenure, he held a wide range of leadership roles including brand marketing for in-market and developing products, sales, and marketing operational excellence.

Bill attended the University of Florida in Gainesville where he received his Doctor of Pharmacy (Pharm.D.) and Master of Business Administration degrees.

The “Kodak-Moment” Dodge: Brand Marketing in a Post-Pandemic World


Pharma brand marketing is being challenged to respond in innovative ways or risk facing a “Kodak moment.” For competitive survival, marketers must embrace creative fear to find relevant and effective new ways to engage with consumers. Digital innovation requires navigating the healthcare ecosystem across all platforms, including points of care.